Is this NASH poster from EASL the source of positive comments: ...... Liver Congress
Efficacy and Safety of Leronlimab in Patients with Nonalcoholic Steatohepatitis (NASH): NASH01 Clinical Study
Asking before i have to copy/paste the 4 pages
(2)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-